What are the symptoms of Neisseria (N.) meningitidis infection, also known as Meningococcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Meningococcemia symptoms typically include fever, headache, and a characteristic petechial or purpuric rash, which can rapidly progress to life-threatening sepsis, and require immediate medical attention. The initial symptoms often resemble flu-like illness with general malaise, and as the infection progresses, patients may develop severe muscle pain, cold hands and feet, abnormal skin color, neck stiffness, photophobia, confusion, and in severe cases, shock with decreased blood pressure and rapid heart rate 1. According to the UK Joint Specialist Societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults, the presence or absence of headache, altered mental status, neck stiffness, fever, rash, seizures, and any signs of shock should be documented 1.

Key Symptoms

  • Fever
  • Headache
  • Petechial or purpuric rash
  • Severe muscle pain
  • Cold hands and feet
  • Abnormal skin color
  • Neck stiffness
  • Photophobia
  • Confusion
  • Shock with decreased blood pressure and rapid heart rate

Importance of Early Intervention

Early intervention significantly improves survival rates and reduces the risk of serious complications like limb loss, neurological damage, or death. Rapid admission to hospital, via an emergency ambulance, should be arranged so that, where possible, the patient arrives within an hour of being assessed in the community 1. Meningococcemia is caused by the bacterium Neisseria meningitidis entering the bloodstream and requires immediate treatment with antibiotics such as ceftriaxone or penicillin G. Anyone suspecting meningococcemia should seek emergency medical care immediately.

From the FDA Drug Label

Meningococcal meningitis and / or septicemia Neisseria meningitidis The symptoms of Meningococcemia are not directly listed in the drug label, but it is indicated that Penicillin G Potassium for Injection, USP is used to treat Meningococcal meningitis and/or septicemia caused by Neisseria meningitidis 2.

  • The drug label does not provide a list of symptoms for Meningococcemia.
  • Meningococcemia is a serious infection, and its symptoms can be severe. However, the label does mention that the drug is used to treat meningitis and septicemia, which can be associated with Meningococcemia.

From the Research

Meningococcemia Symptoms

  • Meningococcemia is an infection caused by Neisseria meningitidis, which can lead to severe consequences such as hypotension, disseminated intravascular coagulation (DIC), multiple organ failure, and osteonecrosis due to DIC 3.
  • The disease is characterized by its rapid progression and high morbidity and mortality rates, especially in pediatric patients 4, 5.
  • Symptoms of meningococcemia can include respiratory distress syndrome, myocarditis, cardiovascular collapse, coagulopathies, major skin loss, and limb amputations 5.
  • The gold standard for diagnosis is the bacteriologic isolation of N. meningitidis from body fluids such as blood, cerebrospinal fluid (CSF), synovial fluid, and pleural fluid 3.
  • Prompt recognition and treatment are essential to prevent significant morbidity and mortality, and management of the systemic circulation, respiration, and intracranial pressure is vital for improving the prognosis 3, 4.

Diagnosis and Treatment

  • Blood, CSF, and skin biopsy cultures are used for diagnosis 3.
  • Antibiotic therapy and intensive supportive care are required for treatment 3, 6.
  • Research into more effective treatment for meningococcemia continues, with studies evaluating the effectiveness of different antibiotics such as ceftriaxone, penicillin, and rifampin 6, 7.
  • Prophylaxis is considered for close contacts of people with a meningococcal infection and populations with known high carriage rates 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Meningococcemia in Adults: A Review of the Literature.

Internal medicine (Tokyo, Japan), 2016

Research

Meningococcemia: epidemiology, pathophysiology, and management.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 2007

Research

Meningococcemia: recognizing and reducing complications in pediatric patients.

AACN clinical issues in critical care nursing, 1994

Research

Ceftriaxone versus penicillin G in the short-term treatment of meningococcal meningitis in adults.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993

Research

Antibiotics for preventing meningococcal infections.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.